2010年卵巢癌NCCN指南(中国版)

卵巢癌Leabharlann NCCN特别鸣谢NCCN指南中国版专家组 召集人：
孙 燕 中国医学科学院北京协和医学院 肿瘤医院
肿瘤学临床实践指南(中国版) 2010年 第一版
NCCN ®
NCCN卵巢癌临床实践指南（中国版）专家组
组 长：
沈 铿 中国医学科学院北京协和医学院北京协和医院
执笔人：
刘继红 中山大学附属肿瘤医院
NCCN
®
肿瘤学临床实践指南(中国版) 2010年 第一版
卵巢癌
NCCN卵巢癌专家组成员
* Robert J. Morgan, Jr., MD/Chair ‡ City of Hope Comprehensive Cancer Center * Ronald D. Alvarez, MD Ω University of Alabama at Birmingham Comprehensive Cancer Center * Deborah K. Armstrong, MD † Ω The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Barry Boston, MD † £ St. Jude Children’s Hospital/University of Tennessee Cancer Institute * Robert A. Burger, MD Ω Fox Chase Cancer Center * Lee-may Chen, MD Ω UCSF Helen Diller Family Comprehensive Cancer Center * Larry Copeland, MD Ω Arthur G. James Cancer Hospital & Richard J. Solove Research Institute at The Ohio State University Marta Ann Crispens, MD Ω Vanderbilt-Ingram Cancer Center * David K. Gaffney, MD, PhD § Huntsman Cancer Institute at the University of Utah
Ω 妇科肿瘤 ‡ 血液科/血液肿瘤科 † 肿瘤内科 § 放疗/放射肿瘤科
Þ 内科 £ 包括姑息治疗和疼痛 处理的支持治疗 * 编委会成员
© National Comprehensive Cancer Network, Inc. All rights reserved. These guidelines and this illustration may not be reproduced in any form without the express written permission of NCCN. The Chinese edition 2010 is the collaborative outcome of the National Comprehensive Cancer Network and Chinese key opinion leaders of the field. Translated and adapted with permission and endorsement from the National Comprehensive Cancer Network. To view the most recent and complete version of this or any other guideline, visit .
成 员（按拼音排序）：
曹泽毅 清华大学第二附属医院 崔 恒 北京大学人民医院 狄 文 上海交通大学医学院附属仁济医院 丰有吉 复旦大学附属妇产科医院 高雨农 北京大学临床肿瘤学院、北京肿瘤医院 郭丽娜 中国医学科学院北京协和医学院北京协和医院 郝 权 天津医科大学附属肿瘤医院 孔北华 山东大学齐鲁医院 郎景和 中国医学科学院北京协和医学院北京协和医院 李 力 广西医科大学附属肿瘤医院 李子庭 复旦大学附属肿瘤医院 林仲秋 中山大学附属第二医院 刘丽影 中国医学科学院北京协和医学院肿瘤医院 马 丁 华中科技大学同济医学院附属同济医院 盛修贵 山东省肿瘤医院 宋 磊 中国人民解放军总医院(三○一医院) 魏丽惠 北京大学人民医院 吴令英 中国医学科学院北京协和医学院肿瘤医院 吴 鸣 中国医学科学院北京协和医学院北京协和医院 吴 强 江苏省肿瘤医院 吴小华 复旦大学附属肿瘤医院 向 阳 中国医学科学院北京协和医学院北京协和医院 谢 幸 浙江大学医学院附属妇产科医院 张福泉 中国医学科学院北京协和医学院北京协和医院
* Ursula A. Matulonis, MD † Dana-Farber/Brigham and Women’s Cancer Center * David M. O’Malley, MD Ω Arthur G. James Cancer Hospital & Richard J. Solove Research Institute at The Ohio State University * Richard T. Penson, MD, MRCP † Massachusetts General Hospital Cancer Center * Steven W. Remmenga, MD Ω UNMC Eppley Cancer Center at The Nebraska Medical Center Paul Sabbatini, MD † Þ Memorial Sloan-Kettering Cancer Center * Russell J. Schilder, MD† ‡ Fox Chase Cancer Center * Julian Schink, MD Ω Robert H. Lurie Comprehensive Cancer Center of Northwestern University Nelson Teng, MD, PhD Ω Stanford Comprehensive Cancer Center
* David Gershenson, MD Ω The University of Texas M. D. Anderson Cancer Center Heidi Gray, MD Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance * Benjamin E. Greer, MD Ω Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance Perry W. Grigsby, MD, MS, MBA § Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine * Laura J. Havrilesky, MD Ω Duke Comprehensive Cancer Center Carolyn Johnston, MD Ω University of Michigan Comprehensive Cancer Center * Johnathan M. Lancaster, MD, PhD Ω H. Lee Moffitt Cancer Center & Research Institute * Shashikant Lele, MD Ω Roswell Park Cancer Institute * Maurie Markman, MD † Ω The University of Texas M. D. Anderson Cancer Center
Copyright © National Comprehensive Cancer Network 2010. All rights reserved. “NCCN”, the NCCN logo, and “National Comprehensive Cancer Network” are registered trademarks of the National Comprehensive Cancer Network. The Chinese edition of NCCN Clinical Practice Guidelines in Oncology-Ovarian Cancer Guideline 2010 is the Chinese adapted version of NCCN Clinical Practice Guidelines in Oncology-Ovarian Cancer Guideline, V.2.2010 as permitted and endorsed by NCCN. It is the collaborative outcome of the National Comprehensive Cancer Network and Chinese key opinion leaders of the field. The original guideline and Chinese edition are both available at: . To view the most recent and complete version of the guideline, go online to . These Guidelines and illustrations herein may not be reproduced in any form for any purpose without the express written permission of the NCCN. These Guidelines are a work in progress that will be refined as often as new significant data becomes available. The NCCN Guidelines are a statement of consensus of its authors regarding their views of currently accepted approaches to treatment. Any clinician seeking to apply or consult any NCCN guideline is expected to use independent medical judgment in the context of individual clinical circumstance to determine any patient's care or treatment. The National Comprehensive Cancer Network makes no warranties of any kind whatsoever regarding their content, use or application and disclaims any responsibility for their application or use in any way. This publication should not be used for commercial purpose. It is provided for free to Chinese medical professions with the support of the unrestrictive educational grant of GlaxoSmithKline (China) Investment Co., Ltd. which exerts no influence to the formation of the Chinese edition of NCCN Clinical Practice Guidelines in Oncology-Ovarian Cancer Guideline 2010.